Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
2.170
-0.080 (-3.56%)
At close: Apr 1, 2025, 4:00 PM
2.162
-0.008 (-0.37%)
After-hours: Apr 1, 2025, 7:17 PM EDT

Mereo BioPharma Group Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
34554232388174242
Upgrade
Market Cap Growth
67.64%67.64%269.38%-49.64%-28.05%276.02%
Upgrade
Enterprise Value
2824682821750221
Upgrade
Last Close Price
2.173.502.310.751.603.58
Upgrade
PE Ratio
----13.66-
Upgrade
PS Ratio
-32.34-4.77-
Upgrade
PB Ratio
5.528.896.401.701.98-16.14
Upgrade
P/TBV Ratio
8.998.996.541.702.74-
Upgrade
EV/Sales Ratio
-28.17-1.38-
Upgrade
Debt / Equity Ratio
0.110.110.120.300.19-1.20
Upgrade
Asset Turnover
--0.14-0.39-
Upgrade
Quick Ratio
5.245.246.382.897.663.23
Upgrade
Current Ratio
5.405.406.723.097.923.47
Upgrade
Return on Equity (ROE)
-77.58%-77.58%-57.81%-53.63%34.85%-1294.27%
Upgrade
Return on Assets (ROA)
-39.99%-39.99%-23.57%-28.67%-13.82%-31.43%
Upgrade
Return on Capital (ROIC)
-46.13%-46.13%-27.52%-34.13%-24.29%-62.09%
Upgrade
Earnings Yield
-12.54%-7.98%-9.11%-48.22%7.32%-67.72%
Upgrade
FCF Yield
-9.52%-6.06%-6.54%-55.78%-3.32%-11.74%
Upgrade
Buyback Yield / Dilution
-12.16%-12.16%-9.33%-8.63%-63.82%-279.04%
Upgrade
Updated Mar 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q